Bone News and Research

RSS

The importance of the endocannabinoid-system

Cannabis (marijuana) is the most widely produced plant-based illicit drug worldwide and the illegal drug most frequently used in Europe.

15 Oct 2007

Quick new method nails adenoviruses in 48 hours

New techniques have enabled scientists to carry one of the most comprehensive studies of adenoviruses ever performed in the United States.

15 Oct 2007

New rapid and accurate method to identify adenoviruses

Grantees of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have adapted a rapid and accurate new molecular typing strategy and used it to conduct one of the most comprehensive studies of adenoviruses ever performed in the United States.

12 Oct 2007

$Prostate cancer increases likelihood of hip fracture four fold$

Prostate cancer increases likelihood of hip fracture four fold

Men who have prostate cancer are on average four times more likely to suffer a hip fracture, with rates rising to eight times in men aged 50 to 65, according to a study of more than 60,000 men published in the October issue of the urology journal BJU International.

12 Oct 2007

New molecules discovered that block cancer cells from modifying cell DNA

Researchers have discovered new small molecules that may prevent prostate cancer cells from turning off normal genes in a process that transforms normal cells into cancer cells. This significant discovery in the field of epigenetics has immediate implications in the development of new diagnostic tests and cancer medications.

12 Oct 2007

Research shows how stem cells decide to become either skeletal or smooth muscle

Researchers have discovered a key protein that controls how stem cells "choose" to become either skeletal muscle cells that move limbs, or smooth muscle cells that support blood vessels, according to a study published in the Proceedings of the National Academy of Sciences (PNAS).

11 Oct 2007

New understanding of stem cell aging

The Stowers Institute's Xie Lab has published recent findings that reveal some of the factors underlying the aging of stem cells.

11 Oct 2007

Rare bone marrow transplant procedure as University of California, San Diego Medical Center

Patients living with Myasthenia Gravis (MG) may breathe easier thanks to a rare bone marrow transplant procedure performed at The Bone Marrow Transplant Program at University of California, San Diego Medical Center, the only program in the western United States that has attempted this procedure.

10 Oct 2007

New device ensures nuclear medicine safer than ever

Hospitals are now able to ensure that the correct dose is administered to the 670,000 patients that undergo nuclear medicine procedures every year due to a new device developed by scientists at the National Physical Laboratory (NPL).

10 Oct 2007

Injectable macro-porous material, for the treatment of bone diseases such as osteoporosis

Researchers of the BIOMAT (Biomaterials Centre) of the Universidad de La Habana have obtained an injectable macro-porous material, useful for the treatment of degenerative diseases such as osteoporosis, to refill bone cavities and in stomatology.

10 Oct 2007

Bacteria reveal targets of immune responses quick and direct identification of antigens

The Epstein-Barr virus (EBV) is a widespread herpes virus that infects more than 90 per cent of the worldwide human population.

10 Oct 2007

Adult stem cells lack key pluripotency regulator

The protein Oct4 plays a major role in embryonic stem cells, acting as a master regulator of the genes that keep the cells in an undifferentiated state.

10 Oct 2007

Paving the way for future pan-European clinical trials

Pan-European collaboration is important for many clinical trials and essential for trials that are investigating treatments for rare diseases.

10 Oct 2007

$Accentia announces investigational new drug application for Revimmune for refractory MS$

Accentia announces investigational new drug application for Revimmune for refractory MS

Accentia Biopharmaceuticals has announced that it met with the Food and Drug Administration (FDA) on September 26, 2007 for a scheduled pre-Investigational New Drug (pre-IND) meeting on Revimmune.

10 Oct 2007

Researchers create microvascular system to nourish growing tissues

One day soon, laboratories may grow synthetically engineered tissues such as muscle or cartilage needed for transplants.

9 Oct 2007

Link between woman's hips and daughter's risk of breast cancer

In a study of the maternity records of more than 6,000 women, David J.P. Barker, M.D., Ph.D., and Kent Thornburg, Ph.D., of Oregon Health & Science University discovered a strong correlation between the size and shape of a woman's hips and her daughter's risk of breast cancer.

9 Oct 2007

Central nervous system infections after heart transplants

Central nervous system infections develop infrequently following heart transplants but are a significant predictor of death, according to an article posted online today that will appear in the December 2007 print issue of Archives of Neurology, one of the JAMA/Archives journals.

9 Oct 2007

Fraunhofer pharmaceutical agent speeds drug development

It takes a great deal of time and money to develop a new drug. At Biotechnica in Hanover from October 9 to 11, the Fraunhofer Life Sciences Alliance will demonstrate how a pharmaceutical agent can make its way more quickly from the research laboratory to the pharmacy.

8 Oct 2007

Bayer HealthCare clear to acquire Citracal calcium supplements in the United States

Bayer HealthCare (BHC) has announced that its Consumer Care Division has received regulatory approvals necessary to acquire the Citracal line of over-the-counter (OTC) calcium supplements in the United States.

8 Oct 2007

Thalidomide therapy helps elderly myeloma patients live longer

The drug thalidomide is making a comeback as a cancer fighting therapy and has been successfully used along with standard therapy to treat the blood cancer myeloma.

7 Oct 2007